90 related articles for article (PubMed ID: 26000254)
1. Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy.
Mohsenzadegan M; Tajik N; Madjd Z; Shekarabi M; Farajollahi MM
Med J Islam Repub Iran; 2015; 29():159. PubMed ID: 26000254
[TBL] [Abstract][Full Text] [Related]
2. NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells.
Das S; Hahn Y; Nagata S; Willingham MC; Bera TK; Lee B; Pastan I
Cancer Res; 2007 Feb; 67(4):1594-601. PubMed ID: 17308099
[TBL] [Abstract][Full Text] [Related]
3. NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate.
Bera TK; Das S; Maeda H; Beers R; Wolfgang CD; Kumar V; Hahn Y; Lee B; Pastan I
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3059-64. PubMed ID: 14981236
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.
Mohsenzadegan M; Madjd Z; Asgari M; Abolhasani M; Shekarabi M; Taeb J; Shariftabrizi A
Cancer Immunol Immunother; 2013 Oct; 62(10):1609-18. PubMed ID: 23955683
[TBL] [Abstract][Full Text] [Related]
5. Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level.
Das S; Hahn Y; Walker DA; Nagata S; Willingham MC; Peehl DM; Bera TK; Lee B; Pastan I
Cancer Res; 2008 Aug; 68(15):6306-12. PubMed ID: 18676855
[TBL] [Abstract][Full Text] [Related]
6. Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer.
Mohsenzadegan M; Shekarabi M; Madjd Z; Asgari M; Abolhasani M; Tajik N; Farajollahi MM
Biomark Med; 2015; 9(4):391-401. PubMed ID: 25808443
[TBL] [Abstract][Full Text] [Related]
7. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
Maddalena ME; Fox J; Chen J; Feng W; Cagnolini A; Linder KE; Tweedle MF; Nunn AD; Lantry LE
J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
[TBL] [Abstract][Full Text] [Related]
8. γ-Oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines.
Hirsch GE; Parisi MM; Martins LA; Andrade CM; Barbé-Tuana FM; Guma FT
Prostate; 2015 Jun; 75(8):783-97. PubMed ID: 25619388
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
10. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
11. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
15. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
16. Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase.
Cifuentes E; Croxen R; Menon M; Barrack ER; Reddy GP
J Cell Physiol; 2003 Jun; 195(3):337-45. PubMed ID: 12704643
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
Hobisch A; Fiechtl M; Sandahl-Sorensen B; Godoy-Tundidor S; Artner-Dworzak E; Ramoner R; Bartsch G; Culig Z
Prostate; 2004 Jun; 59(4):401-8. PubMed ID: 15065088
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancer.
Battista MC; Guimond MO; Roberge C; Doueik AA; Fazli L; Gleave M; Sabbagh R; Gallo-Payet N
Prostate; 2010 Jun; 70(9):921-33. PubMed ID: 20166102
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
